CEO
weezion
The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.
- Biotechnology
- Healthcare Technology
Updated 5 months ago
Funding
Raised to date
$2.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.